Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.18 | -15.27 |
| PEG Ratio (TTM) | 0.00 | -4.35 |
| P/S Ratio (TTM) | 3.46 | 45.97 |
| P/B Ratio (TTM) | 0.16 | 28.96 |
| P/FCF Ratio (TTM) | 0.00 | -2.59 |
| Price to 5YR AVG Earnings Ratio | N/A | -5.56 |
| Price to 5YR AVG FCF Ratio | N/A | -12.33 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -84.64% | -19.06% |
| ROE (TTM) | -81.66% | 15.70% |
| Net Profit Margin (TTM) | -1,615.79% | -813.88% |
| ROIC 5YR AVG | N/A | 3.12% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -5.73% | -1,181.97% | N/A |
| Revenue | -25.00% | 1,010.13% | N/A |
| Net Income | 1.51% | -1,909.13% | N/A |
| Cash Flow | -70,997.47% | -2,787.64% | N/A |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 14,807.41 | 5.56 |
| Quick Ratio (TTM) | 14,807.41 | 5.34 |
| D/E Ratio (TTM) | N/A | 0.95 |
| Interest Coverage (TTM) | N/A | -6.44 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | N/A | 12.45 |
| LTL to 5YR AVG FCF | N/A | 0.11 |
| Shares Outstanding Growth 5YR AVG | N/A | 37.46% |